nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP2C9—Diclofenamide—glaucoma	0.0877	0.167	CbGbCtD
Glipizide—CYP2C9—Dorzolamide—glaucoma	0.0847	0.162	CbGbCtD
Glipizide—CYP2C9—Methazolamide—glaucoma	0.0755	0.144	CbGbCtD
Glipizide—CYP3A4—Pilocarpine—glaucoma	0.065	0.124	CbGbCtD
Glipizide—CYP3A4—Brinzolamide—glaucoma	0.051	0.0973	CbGbCtD
Glipizide—CYP3A4—Dorzolamide—glaucoma	0.0492	0.094	CbGbCtD
Glipizide—CYP3A4—Methazolamide—glaucoma	0.0439	0.0838	CbGbCtD
Glipizide—CYP3A4—Acetazolamide—glaucoma	0.0351	0.067	CbGbCtD
Glipizide—CYP3A4—Clonidine—glaucoma	0.0317	0.0606	CbGbCtD
Glipizide—Glyburide—ABCA1—glaucoma	0.00339	0.513	CrCbGaD
Glipizide—Gliclazide—VEGFA—glaucoma	0.00322	0.487	CrCbGaD
Glipizide—ABCC8—ABC-family proteins mediated transport—PEX19—glaucoma	0.00269	0.145	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—ATOH7—glaucoma	0.000756	0.0408	CbGpPWpGaD
Glipizide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.000572	0.0308	CbGpPWpGaD
Glipizide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000541	0.0292	CbGpPWpGaD
Glipizide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000492	0.0265	CbGpPWpGaD
Glipizide—PPARG—Transcription factor regulation in adipogenesis—NR3C1—glaucoma	0.000484	0.0261	CbGpPWpGaD
Glipizide—Anorexia—Pilocarpine—glaucoma	0.000463	0.00103	CcSEcCtD
Glipizide—Feeling abnormal—Acetazolamide—glaucoma	0.000462	0.00102	CcSEcCtD
Glipizide—Hypersensitivity—Apraclonidine—glaucoma	0.000462	0.00102	CcSEcCtD
Glipizide—Nervousness—Clonidine—glaucoma	0.000462	0.00102	CcSEcCtD
Glipizide—Paraesthesia—Dorzolamide—glaucoma	0.000462	0.00102	CcSEcCtD
Glipizide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000461	0.0249	CbGpPWpGaD
Glipizide—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000461	0.00102	CcSEcCtD
Glipizide—Pain—Brimonidine—glaucoma	0.000461	0.00102	CcSEcCtD
Glipizide—Dyspnoea—Dorzolamide—glaucoma	0.000459	0.00102	CcSEcCtD
Glipizide—Visual impairment—Betaxolol—glaucoma	0.000458	0.00102	CcSEcCtD
Glipizide—Insomnia—Brinzolamide—glaucoma	0.000457	0.00101	CcSEcCtD
Glipizide—Somnolence—Dorzolamide—glaucoma	0.000457	0.00101	CcSEcCtD
Glipizide—Muscle spasms—Clonidine—glaucoma	0.000457	0.00101	CcSEcCtD
Glipizide—Dyspnoea—Travoprost—glaucoma	0.000457	0.00101	CcSEcCtD
Glipizide—Paraesthesia—Brinzolamide—glaucoma	0.000454	0.00101	CcSEcCtD
Glipizide—Dysuria—Timolol—glaucoma	0.000454	0.00101	CcSEcCtD
Glipizide—Dyspepsia—Dorzolamide—glaucoma	0.000453	0.001	CcSEcCtD
Glipizide—Dyspnoea—Brinzolamide—glaucoma	0.000451	0.000999	CcSEcCtD
Glipizide—Dyspepsia—Travoprost—glaucoma	0.000451	0.000999	CcSEcCtD
Glipizide—Asthenia—Apraclonidine—glaucoma	0.00045	0.000998	CcSEcCtD
Glipizide—Somnolence—Brinzolamide—glaucoma	0.00045	0.000996	CcSEcCtD
Glipizide—Vision blurred—Clonidine—glaucoma	0.000448	0.000993	CcSEcCtD
Glipizide—Decreased appetite—Dorzolamide—glaucoma	0.000447	0.000991	CcSEcCtD
Glipizide—Urticaria—Acetazolamide—glaucoma	0.000446	0.000988	CcSEcCtD
Glipizide—Tremor—Clonidine—glaucoma	0.000446	0.000987	CcSEcCtD
Glipizide—Dyspepsia—Brinzolamide—glaucoma	0.000445	0.000986	CcSEcCtD
Glipizide—Eye disorder—Betaxolol—glaucoma	0.000444	0.000985	CcSEcCtD
Glipizide—Pruritus—Apraclonidine—glaucoma	0.000444	0.000984	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000443	0.000981	CcSEcCtD
Glipizide—Gastrointestinal disorder—Travoprost—glaucoma	0.000442	0.00098	CcSEcCtD
Glipizide—Flushing—Betaxolol—glaucoma	0.000441	0.000978	CcSEcCtD
Glipizide—Ill-defined disorder—Clonidine—glaucoma	0.000441	0.000978	CcSEcCtD
Glipizide—Pain—Dorzolamide—glaucoma	0.00044	0.000975	CcSEcCtD
Glipizide—Insomnia—Pilocarpine—glaucoma	0.00044	0.000974	CcSEcCtD
Glipizide—Decreased appetite—Brinzolamide—glaucoma	0.00044	0.000974	CcSEcCtD
Glipizide—Pain—Travoprost—glaucoma	0.000438	0.000971	CcSEcCtD
Glipizide—Constipation—Travoprost—glaucoma	0.000438	0.000971	CcSEcCtD
Glipizide—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000437	0.000968	CcSEcCtD
Glipizide—Paraesthesia—Pilocarpine—glaucoma	0.000436	0.000967	CcSEcCtD
Glipizide—Asthenia—Bimatoprost—glaucoma	0.000436	0.000967	CcSEcCtD
Glipizide—Dyspnoea—Pilocarpine—glaucoma	0.000433	0.00096	CcSEcCtD
Glipizide—Pain—Brinzolamide—glaucoma	0.000432	0.000958	CcSEcCtD
Glipizide—Somnolence—Pilocarpine—glaucoma	0.000432	0.000958	CcSEcCtD
Glipizide—Pruritus—Bimatoprost—glaucoma	0.00043	0.000954	CcSEcCtD
Glipizide—Diarrhoea—Apraclonidine—glaucoma	0.000429	0.000951	CcSEcCtD
Glipizide—Malaise—Clonidine—glaucoma	0.000429	0.00095	CcSEcCtD
Glipizide—Dyspepsia—Pilocarpine—glaucoma	0.000428	0.000948	CcSEcCtD
Glipizide—Chills—Betaxolol—glaucoma	0.000427	0.000946	CcSEcCtD
Glipizide—Syncope—Clonidine—glaucoma	0.000426	0.000945	CcSEcCtD
Glipizide—Arrhythmia—Betaxolol—glaucoma	0.000425	0.000942	CcSEcCtD
Glipizide—Feeling abnormal—Dorzolamide—glaucoma	0.000424	0.000939	CcSEcCtD
Glipizide—Decreased appetite—Pilocarpine—glaucoma	0.000422	0.000936	CcSEcCtD
Glipizide—Feeling abnormal—Travoprost—glaucoma	0.000422	0.000935	CcSEcCtD
Glipizide—Conjunctivitis—Timolol—glaucoma	0.000421	0.000932	CcSEcCtD
Glipizide—Gastrointestinal pain—Dorzolamide—glaucoma	0.000421	0.000932	CcSEcCtD
Glipizide—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00042	0.00093	CcSEcCtD
Glipizide—Gastrointestinal pain—Travoprost—glaucoma	0.000419	0.000928	CcSEcCtD
Glipizide—Loss of consciousness—Clonidine—glaucoma	0.000418	0.000926	CcSEcCtD
Glipizide—Feeling abnormal—Brinzolamide—glaucoma	0.000417	0.000923	CcSEcCtD
Glipizide—Constipation—Pilocarpine—glaucoma	0.000416	0.000921	CcSEcCtD
Glipizide—Pain—Pilocarpine—glaucoma	0.000416	0.000921	CcSEcCtD
Glipizide—Sweating—Timolol—glaucoma	0.000415	0.00092	CcSEcCtD
Glipizide—Dizziness—Apraclonidine—glaucoma	0.000415	0.000919	CcSEcCtD
Glipizide—Erythema—Betaxolol—glaucoma	0.000414	0.000918	CcSEcCtD
Glipizide—Urticaria—Dorzolamide—glaucoma	0.000409	0.000906	CcSEcCtD
Glipizide—Abdominal pain—Dorzolamide—glaucoma	0.000407	0.000901	CcSEcCtD
Glipizide—Tension—Betaxolol—glaucoma	0.000406	0.0009	CcSEcCtD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—HDAC9—glaucoma	0.000406	0.0219	CbGpPWpGaD
Glipizide—Arthralgia—Clonidine—glaucoma	0.000405	0.000897	CcSEcCtD
Glipizide—Abdominal pain—Travoprost—glaucoma	0.000405	0.000897	CcSEcCtD
Glipizide—Agranulocytosis—Timolol—glaucoma	0.000404	0.000895	CcSEcCtD
Glipizide—Anxiety—Clonidine—glaucoma	0.000403	0.000894	CcSEcCtD
Glipizide—Asthenia—Acetazolamide—glaucoma	0.000403	0.000892	CcSEcCtD
Glipizide—Dizziness—Bimatoprost—glaucoma	0.000402	0.000891	CcSEcCtD
Glipizide—Nervousness—Betaxolol—glaucoma	0.000402	0.000891	CcSEcCtD
Glipizide—Urticaria—Brinzolamide—glaucoma	0.000402	0.00089	CcSEcCtD
Glipizide—Feeling abnormal—Pilocarpine—glaucoma	0.000401	0.000888	CcSEcCtD
Glipizide—Discomfort—Clonidine—glaucoma	0.0004	0.000887	CcSEcCtD
Glipizide—Vomiting—Apraclonidine—glaucoma	0.000399	0.000884	CcSEcCtD
Glipizide—Muscle spasms—Betaxolol—glaucoma	0.000398	0.000882	CcSEcCtD
Glipizide—Gastrointestinal pain—Pilocarpine—glaucoma	0.000397	0.000881	CcSEcCtD
Glipizide—Hypersensitivity—Brimonidine—glaucoma	0.000397	0.000879	CcSEcCtD
Glipizide—Dermatitis—Apraclonidine—glaucoma	0.000395	0.000876	CcSEcCtD
Glipizide—Headache—Apraclonidine—glaucoma	0.000393	0.000871	CcSEcCtD
Glipizide—Confusional state—Clonidine—glaucoma	0.000391	0.000867	CcSEcCtD
Glipizide—Vision blurred—Betaxolol—glaucoma	0.00039	0.000865	CcSEcCtD
Glipizide—Rhinitis—Timolol—glaucoma	0.00039	0.000863	CcSEcCtD
Glipizide—Oedema—Clonidine—glaucoma	0.000388	0.00086	CcSEcCtD
Glipizide—Tremor—Betaxolol—glaucoma	0.000388	0.00086	CcSEcCtD
Glipizide—ABCC8—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	0.000388	0.0209	CbGpPWpGaD
Glipizide—Asthenia—Brimonidine—glaucoma	0.000386	0.000856	CcSEcCtD
Glipizide—Abdominal pain—Pilocarpine—glaucoma	0.000384	0.000851	CcSEcCtD
Glipizide—Ill-defined disorder—Betaxolol—glaucoma	0.000384	0.000851	CcSEcCtD
Glipizide—Diarrhoea—Acetazolamide—glaucoma	0.000384	0.000851	CcSEcCtD
Glipizide—Rash—Bimatoprost—glaucoma	0.000383	0.00085	CcSEcCtD
Glipizide—Dermatitis—Bimatoprost—glaucoma	0.000383	0.000849	CcSEcCtD
Glipizide—Shock—Clonidine—glaucoma	0.000382	0.000846	CcSEcCtD
Glipizide—Pruritus—Brimonidine—glaucoma	0.000381	0.000844	CcSEcCtD
Glipizide—Headache—Bimatoprost—glaucoma	0.000381	0.000844	CcSEcCtD
Glipizide—Thrombocytopenia—Clonidine—glaucoma	0.00038	0.000842	CcSEcCtD
Glipizide—Hypersensitivity—Dorzolamide—glaucoma	0.000379	0.00084	CcSEcCtD
Glipizide—Hypersensitivity—Travoprost—glaucoma	0.000377	0.000836	CcSEcCtD
Glipizide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	0.000376	0.0203	CbGpPWpGaD
Glipizide—Hyperhidrosis—Clonidine—glaucoma	0.000375	0.000832	CcSEcCtD
Glipizide—Visual impairment—Timolol—glaucoma	0.000374	0.00083	CcSEcCtD
Glipizide—Malaise—Betaxolol—glaucoma	0.000373	0.000827	CcSEcCtD
Glipizide—Nausea—Apraclonidine—glaucoma	0.000373	0.000826	CcSEcCtD
Glipizide—Hypersensitivity—Brinzolamide—glaucoma	0.000373	0.000826	CcSEcCtD
Glipizide—Vertigo—Betaxolol—glaucoma	0.000372	0.000824	CcSEcCtD
Glipizide—Syncope—Betaxolol—glaucoma	0.000371	0.000823	CcSEcCtD
Glipizide—Dizziness—Acetazolamide—glaucoma	0.000371	0.000822	CcSEcCtD
Glipizide—Anorexia—Clonidine—glaucoma	0.00037	0.00082	CcSEcCtD
Glipizide—Asthenia—Dorzolamide—glaucoma	0.000369	0.000818	CcSEcCtD
Glipizide—Asthenia—Travoprost—glaucoma	0.000367	0.000814	CcSEcCtD
Glipizide—Pruritus—Dorzolamide—glaucoma	0.000364	0.000806	CcSEcCtD
Glipizide—Loss of consciousness—Betaxolol—glaucoma	0.000364	0.000806	CcSEcCtD
Glipizide—Eye disorder—Timolol—glaucoma	0.000363	0.000805	CcSEcCtD
Glipizide—Asthenia—Brinzolamide—glaucoma	0.000363	0.000804	CcSEcCtD
Glipizide—Pruritus—Travoprost—glaucoma	0.000362	0.000803	CcSEcCtD
Glipizide—Nausea—Bimatoprost—glaucoma	0.000361	0.000801	CcSEcCtD
Glipizide—Hypersensitivity—Pilocarpine—glaucoma	0.000358	0.000794	CcSEcCtD
Glipizide—Pruritus—Brinzolamide—glaucoma	0.000358	0.000793	CcSEcCtD
Glipizide—Vomiting—Acetazolamide—glaucoma	0.000357	0.000791	CcSEcCtD
Glipizide—Dizziness—Brimonidine—glaucoma	0.000356	0.000789	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Clonidine—glaucoma	0.000354	0.000784	CcSEcCtD
Glipizide—Arthralgia—Betaxolol—glaucoma	0.000352	0.000781	CcSEcCtD
Glipizide—Myalgia—Betaxolol—glaucoma	0.000352	0.000781	CcSEcCtD
Glipizide—Diarrhoea—Dorzolamide—glaucoma	0.000352	0.00078	CcSEcCtD
Glipizide—Headache—Acetazolamide—glaucoma	0.000352	0.000779	CcSEcCtD
Glipizide—Anxiety—Betaxolol—glaucoma	0.000351	0.000778	CcSEcCtD
Glipizide—Insomnia—Clonidine—glaucoma	0.000351	0.000778	CcSEcCtD
Glipizide—Diarrhoea—Travoprost—glaucoma	0.00035	0.000777	CcSEcCtD
Glipizide—Asthenia—Pilocarpine—glaucoma	0.000349	0.000773	CcSEcCtD
Glipizide—Paraesthesia—Clonidine—glaucoma	0.000349	0.000772	CcSEcCtD
Glipizide—Discomfort—Betaxolol—glaucoma	0.000348	0.000772	CcSEcCtD
Glipizide—Arrhythmia—Timolol—glaucoma	0.000347	0.000769	CcSEcCtD
Glipizide—Dyspnoea—Clonidine—glaucoma	0.000346	0.000767	CcSEcCtD
Glipizide—Diarrhoea—Brinzolamide—glaucoma	0.000346	0.000767	CcSEcCtD
Glipizide—Somnolence—Clonidine—glaucoma	0.000345	0.000765	CcSEcCtD
Glipizide—Pruritus—Pilocarpine—glaucoma	0.000344	0.000762	CcSEcCtD
Glipizide—Confusional state—Betaxolol—glaucoma	0.000341	0.000755	CcSEcCtD
Glipizide—Dizziness—Dorzolamide—glaucoma	0.00034	0.000754	CcSEcCtD
Glipizide—Rash—Brimonidine—glaucoma	0.00034	0.000753	CcSEcCtD
Glipizide—Dermatitis—Brimonidine—glaucoma	0.000339	0.000752	CcSEcCtD
Glipizide—Dizziness—Travoprost—glaucoma	0.000339	0.000751	CcSEcCtD
Glipizide—Erythema—Timolol—glaucoma	0.000338	0.00075	CcSEcCtD
Glipizide—Oedema—Betaxolol—glaucoma	0.000338	0.000749	CcSEcCtD
Glipizide—Headache—Brimonidine—glaucoma	0.000337	0.000748	CcSEcCtD
Glipizide—Decreased appetite—Clonidine—glaucoma	0.000337	0.000748	CcSEcCtD
Glipizide—Gastrointestinal disorder—Clonidine—glaucoma	0.000335	0.000743	CcSEcCtD
Glipizide—Dizziness—Brinzolamide—glaucoma	0.000334	0.000741	CcSEcCtD
Glipizide—Nausea—Acetazolamide—glaucoma	0.000333	0.000739	CcSEcCtD
Glipizide—Diarrhoea—Pilocarpine—glaucoma	0.000333	0.000737	CcSEcCtD
Glipizide—Shock—Betaxolol—glaucoma	0.000332	0.000737	CcSEcCtD
Glipizide—Tension—Timolol—glaucoma	0.000332	0.000736	CcSEcCtD
Glipizide—Pain—Clonidine—glaucoma	0.000332	0.000736	CcSEcCtD
Glipizide—Constipation—Clonidine—glaucoma	0.000332	0.000736	CcSEcCtD
Glipizide—Thrombocytopenia—Betaxolol—glaucoma	0.000331	0.000733	CcSEcCtD
Glipizide—Nervousness—Timolol—glaucoma	0.000329	0.000728	CcSEcCtD
Glipizide—Vomiting—Dorzolamide—glaucoma	0.000327	0.000725	CcSEcCtD
Glipizide—Hyperhidrosis—Betaxolol—glaucoma	0.000327	0.000724	CcSEcCtD
Glipizide—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000325	0.0175	CbGpPWpGaD
Glipizide—Rash—Dorzolamide—glaucoma	0.000324	0.000719	CcSEcCtD
Glipizide—Dermatitis—Dorzolamide—glaucoma	0.000324	0.000718	CcSEcCtD
Glipizide—Rash—Travoprost—glaucoma	0.000323	0.000716	CcSEcCtD
Glipizide—Dermatitis—Travoprost—glaucoma	0.000323	0.000715	CcSEcCtD
Glipizide—Headache—Dorzolamide—glaucoma	0.000322	0.000714	CcSEcCtD
Glipizide—Anorexia—Betaxolol—glaucoma	0.000322	0.000714	CcSEcCtD
Glipizide—Vomiting—Brinzolamide—glaucoma	0.000322	0.000713	CcSEcCtD
Glipizide—Dizziness—Pilocarpine—glaucoma	0.000321	0.000712	CcSEcCtD
Glipizide—Headache—Travoprost—glaucoma	0.000321	0.000711	CcSEcCtD
Glipizide—Nausea—Brimonidine—glaucoma	0.00032	0.000709	CcSEcCtD
Glipizide—Feeling abnormal—Clonidine—glaucoma	0.00032	0.000709	CcSEcCtD
Glipizide—PPARG—Regulation of retinoblastoma protein—TGFB2—glaucoma	0.000319	0.0172	CbGpPWpGaD
Glipizide—Rash—Brinzolamide—glaucoma	0.000319	0.000707	CcSEcCtD
Glipizide—Vision blurred—Timolol—glaucoma	0.000319	0.000706	CcSEcCtD
Glipizide—Dermatitis—Brinzolamide—glaucoma	0.000319	0.000706	CcSEcCtD
Glipizide—Gastrointestinal pain—Clonidine—glaucoma	0.000317	0.000703	CcSEcCtD
Glipizide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000317	0.0171	CbGpPWpGaD
Glipizide—Headache—Brinzolamide—glaucoma	0.000317	0.000702	CcSEcCtD
Glipizide—PPARG—Nuclear Receptors—NR3C1—glaucoma	0.000312	0.0168	CbGpPWpGaD
Glipizide—Vomiting—Pilocarpine—glaucoma	0.000309	0.000685	CcSEcCtD
Glipizide—Urticaria—Clonidine—glaucoma	0.000308	0.000683	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000308	0.000682	CcSEcCtD
Glipizide—Abdominal pain—Clonidine—glaucoma	0.000307	0.00068	CcSEcCtD
Glipizide—Rash—Pilocarpine—glaucoma	0.000306	0.000679	CcSEcCtD
Glipizide—Dermatitis—Pilocarpine—glaucoma	0.000306	0.000679	CcSEcCtD
Glipizide—Insomnia—Betaxolol—glaucoma	0.000306	0.000677	CcSEcCtD
Glipizide—Nausea—Dorzolamide—glaucoma	0.000306	0.000677	CcSEcCtD
Glipizide—Headache—Pilocarpine—glaucoma	0.000304	0.000675	CcSEcCtD
Glipizide—Nausea—Travoprost—glaucoma	0.000304	0.000674	CcSEcCtD
Glipizide—Vertigo—Timolol—glaucoma	0.000304	0.000673	CcSEcCtD
Glipizide—Paraesthesia—Betaxolol—glaucoma	0.000303	0.000672	CcSEcCtD
Glipizide—Syncope—Timolol—glaucoma	0.000303	0.000672	CcSEcCtD
Glipizide—Dyspnoea—Betaxolol—glaucoma	0.000301	0.000668	CcSEcCtD
Glipizide—PPARG—Circadian rythm related genes—OPN4—glaucoma	0.000301	0.0162	CbGpPWpGaD
Glipizide—Nausea—Brinzolamide—glaucoma	0.0003	0.000666	CcSEcCtD
Glipizide—Dyspepsia—Betaxolol—glaucoma	0.000297	0.000659	CcSEcCtD
Glipizide—Loss of consciousness—Timolol—glaucoma	0.000297	0.000659	CcSEcCtD
Glipizide—Decreased appetite—Betaxolol—glaucoma	0.000294	0.000651	CcSEcCtD
Glipizide—Hypertension—Timolol—glaucoma	0.000292	0.000647	CcSEcCtD
Glipizide—Gastrointestinal disorder—Betaxolol—glaucoma	0.000292	0.000647	CcSEcCtD
Glipizide—Pain—Betaxolol—glaucoma	0.000289	0.00064	CcSEcCtD
Glipizide—Constipation—Betaxolol—glaucoma	0.000289	0.00064	CcSEcCtD
Glipizide—Nausea—Pilocarpine—glaucoma	0.000289	0.00064	CcSEcCtD
Glipizide—Myalgia—Timolol—glaucoma	0.000288	0.000638	CcSEcCtD
Glipizide—Arthralgia—Timolol—glaucoma	0.000288	0.000638	CcSEcCtD
Glipizide—Anxiety—Timolol—glaucoma	0.000287	0.000636	CcSEcCtD
Glipizide—Hypersensitivity—Clonidine—glaucoma	0.000286	0.000634	CcSEcCtD
Glipizide—Discomfort—Timolol—glaucoma	0.000285	0.000631	CcSEcCtD
Glipizide—ABCC8—Transmembrane transport of small molecules—PEX19—glaucoma	0.000281	0.0152	CbGpPWpGaD
Glipizide—Asthenia—Clonidine—glaucoma	0.000278	0.000617	CcSEcCtD
Glipizide—Feeling abnormal—Betaxolol—glaucoma	0.000278	0.000617	CcSEcCtD
Glipizide—Confusional state—Timolol—glaucoma	0.000278	0.000617	CcSEcCtD
Glipizide—Oedema—Timolol—glaucoma	0.000276	0.000612	CcSEcCtD
Glipizide—Pruritus—Clonidine—glaucoma	0.000275	0.000609	CcSEcCtD
Glipizide—Shock—Timolol—glaucoma	0.000272	0.000602	CcSEcCtD
Glipizide—KCNJ11—Type II diabetes mellitus—TNF—glaucoma	0.000269	0.0145	CbGpPWpGaD
Glipizide—Urticaria—Betaxolol—glaucoma	0.000268	0.000595	CcSEcCtD
Glipizide—Hyperhidrosis—Timolol—glaucoma	0.000267	0.000591	CcSEcCtD
Glipizide—Diarrhoea—Clonidine—glaucoma	0.000266	0.000589	CcSEcCtD
Glipizide—Anorexia—Timolol—glaucoma	0.000263	0.000583	CcSEcCtD
Glipizide—Dizziness—Clonidine—glaucoma	0.000257	0.000569	CcSEcCtD
Glipizide—PPARG—Regulation of retinoblastoma protein—CCND2—glaucoma	0.000255	0.0138	CbGpPWpGaD
Glipizide—Musculoskeletal discomfort—Timolol—glaucoma	0.000251	0.000557	CcSEcCtD
Glipizide—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.00025	0.0135	CbGpPWpGaD
Glipizide—Insomnia—Timolol—glaucoma	0.00025	0.000553	CcSEcCtD
Glipizide—Hypersensitivity—Betaxolol—glaucoma	0.000249	0.000552	CcSEcCtD
Glipizide—Paraesthesia—Timolol—glaucoma	0.000248	0.000549	CcSEcCtD
Glipizide—PPARG—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000247	0.0133	CbGpPWpGaD
Glipizide—Vomiting—Clonidine—glaucoma	0.000247	0.000547	CcSEcCtD
Glipizide—Dyspnoea—Timolol—glaucoma	0.000246	0.000545	CcSEcCtD
Glipizide—Somnolence—Timolol—glaucoma	0.000245	0.000544	CcSEcCtD
Glipizide—Rash—Clonidine—glaucoma	0.000245	0.000542	CcSEcCtD
Glipizide—Dermatitis—Clonidine—glaucoma	0.000244	0.000542	CcSEcCtD
Glipizide—Headache—Clonidine—glaucoma	0.000243	0.000539	CcSEcCtD
Glipizide—Dyspepsia—Timolol—glaucoma	0.000243	0.000539	CcSEcCtD
Glipizide—Asthenia—Betaxolol—glaucoma	0.000242	0.000537	CcSEcCtD
Glipizide—Decreased appetite—Timolol—glaucoma	0.00024	0.000532	CcSEcCtD
Glipizide—Pruritus—Betaxolol—glaucoma	0.000239	0.00053	CcSEcCtD
Glipizide—Gastrointestinal disorder—Timolol—glaucoma	0.000238	0.000528	CcSEcCtD
Glipizide—Pain—Timolol—glaucoma	0.000236	0.000523	CcSEcCtD
Glipizide—ABCC8—Neuronal System—SLC6A13—glaucoma	0.000236	0.0127	CbGpPWpGaD
Glipizide—Diarrhoea—Betaxolol—glaucoma	0.000231	0.000512	CcSEcCtD
Glipizide—Nausea—Clonidine—glaucoma	0.000231	0.000511	CcSEcCtD
Glipizide—KCNJ11—Neuronal System—SLC6A13—glaucoma	0.000228	0.0123	CbGpPWpGaD
Glipizide—Feeling abnormal—Timolol—glaucoma	0.000227	0.000504	CcSEcCtD
Glipizide—Gastrointestinal pain—Timolol—glaucoma	0.000226	0.0005	CcSEcCtD
Glipizide—Dizziness—Betaxolol—glaucoma	0.000223	0.000495	CcSEcCtD
Glipizide—Urticaria—Timolol—glaucoma	0.000219	0.000486	CcSEcCtD
Glipizide—Abdominal pain—Timolol—glaucoma	0.000218	0.000484	CcSEcCtD
Glipizide—Vomiting—Betaxolol—glaucoma	0.000215	0.000476	CcSEcCtD
Glipizide—Rash—Betaxolol—glaucoma	0.000213	0.000472	CcSEcCtD
Glipizide—Dermatitis—Betaxolol—glaucoma	0.000213	0.000472	CcSEcCtD
Glipizide—Headache—Betaxolol—glaucoma	0.000212	0.000469	CcSEcCtD
Glipizide—Hypersensitivity—Timolol—glaucoma	0.000203	0.000451	CcSEcCtD
Glipizide—Nausea—Betaxolol—glaucoma	0.000201	0.000445	CcSEcCtD
Glipizide—PPARG—Transcription factor regulation in adipogenesis—TNF—glaucoma	0.000199	0.0107	CbGpPWpGaD
Glipizide—Asthenia—Timolol—glaucoma	0.000198	0.000439	CcSEcCtD
Glipizide—Pruritus—Timolol—glaucoma	0.000195	0.000433	CcSEcCtD
Glipizide—ABCC8—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00019	0.0102	CbGpPWpGaD
Glipizide—Diarrhoea—Timolol—glaucoma	0.000189	0.000419	CcSEcCtD
Glipizide—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000186	0.0101	CbGpPWpGaD
Glipizide—Dizziness—Timolol—glaucoma	0.000183	0.000405	CcSEcCtD
Glipizide—PPARG—PPARA activates gene expression—ABCA1—glaucoma	0.00018	0.00973	CbGpPWpGaD
Glipizide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000177	0.00952	CbGpPWpGaD
Glipizide—Vomiting—Timolol—glaucoma	0.000176	0.000389	CcSEcCtD
Glipizide—Rash—Timolol—glaucoma	0.000174	0.000386	CcSEcCtD
Glipizide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000174	0.00939	CbGpPWpGaD
Glipizide—Dermatitis—Timolol—glaucoma	0.000174	0.000385	CcSEcCtD
Glipizide—Headache—Timolol—glaucoma	0.000173	0.000383	CcSEcCtD
Glipizide—ABCC8—Neuronal System—SLC6A1—glaucoma	0.000172	0.0093	CbGpPWpGaD
Glipizide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00017	0.00917	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—SLC6A1—glaucoma	0.000167	0.00902	CbGpPWpGaD
Glipizide—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000165	0.00889	CbGpPWpGaD
Glipizide—Nausea—Timolol—glaucoma	0.000164	0.000363	CcSEcCtD
Glipizide—ABCC8—Metabolism—CA5A—glaucoma	0.000155	0.00835	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NARFL—glaucoma	0.000155	0.00835	CbGpPWpGaD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—glaucoma	0.000153	0.00824	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CA5A—glaucoma	0.00015	0.0081	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NARFL—glaucoma	0.00015	0.0081	CbGpPWpGaD
Glipizide—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000149	0.00804	CbGpPWpGaD
Glipizide—PPARG—Regulation of retinoblastoma protein—CDKN2A—glaucoma	0.000131	0.00706	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000127	0.00683	CbGpPWpGaD
Glipizide—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000125	0.00673	CbGpPWpGaD
Glipizide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000122	0.00656	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000118	0.00636	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—NR3C1—glaucoma	0.000117	0.0063	CbGpPWpGaD
Glipizide—PPARG—Regulation of retinoblastoma protein—CDKN1B—glaucoma	0.000116	0.00625	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—FAS—glaucoma	0.000113	0.0061	CbGpPWpGaD
Glipizide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000112	0.00605	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NARFL—glaucoma	0.000111	0.00599	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CA5A—glaucoma	0.000111	0.00599	CbGpPWpGaD
Glipizide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000108	0.00582	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—NGFR—glaucoma	0.000107	0.00578	CbGpPWpGaD
Glipizide—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000106	0.00574	CbGpPWpGaD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	0.000103	0.00556	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—NTRK1—glaucoma	0.000102	0.00549	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NCK2—glaucoma	0.0001	0.00539	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.27e-05	0.005	CbGpPWpGaD
Glipizide—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	8.8e-05	0.00475	CbGpPWpGaD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.75e-05	0.00472	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—FAS—glaucoma	7.98e-05	0.0043	CbGpPWpGaD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—TNF—glaucoma	7.88e-05	0.00425	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CA1—glaucoma	7.56e-05	0.00408	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CA1—glaucoma	7.33e-05	0.00395	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CTSA—glaucoma	7.32e-05	0.00395	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—glaucoma	7.3e-05	0.00394	CbGpPWpGaD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.11e-05	0.00384	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CTSA—glaucoma	7.1e-05	0.00383	CbGpPWpGaD
Glipizide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.02e-05	0.00379	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CA2—glaucoma	6.92e-05	0.00373	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CA2—glaucoma	6.71e-05	0.00362	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—PAX6—glaucoma	6.48e-05	0.00349	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTT1—glaucoma	5.83e-05	0.00314	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.77e-05	0.00311	CbGpPWpGaD
Glipizide—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	5.63e-05	0.00303	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CA1—glaucoma	5.42e-05	0.00292	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CTSA—glaucoma	5.25e-05	0.00283	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CA2—glaucoma	4.96e-05	0.00267	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—TXN—glaucoma	4.87e-05	0.00263	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—CDKN2B—glaucoma	4.86e-05	0.00262	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.84e-05	0.00261	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.84e-05	0.00261	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—TNF—glaucoma	4.8e-05	0.00259	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—TXN—glaucoma	4.72e-05	0.00255	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP1B1—glaucoma	4.65e-05	0.00251	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	4.58e-05	0.00247	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.34e-05	0.00234	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—NR3C1—glaucoma	4.26e-05	0.0023	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NARFL—glaucoma	4.09e-05	0.0022	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CA5A—glaucoma	4.09e-05	0.0022	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.85e-05	0.00207	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTT1—glaucoma	3.78e-05	0.00204	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTM1—glaucoma	3.71e-05	0.002	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTT1—glaucoma	3.66e-05	0.00198	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	3.66e-05	0.00198	CbGpPWpGaD
Glipizide—PPARG—Metabolism—TXN—glaucoma	3.49e-05	0.00188	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.19e-05	0.00172	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.16e-05	0.0017	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.06e-05	0.00165	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.02e-05	0.00163	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP1B1—glaucoma	3.01e-05	0.00162	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ABCA1—glaucoma	3.01e-05	0.00162	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TP53—glaucoma	2.99e-05	0.00161	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ABCA1—glaucoma	2.92e-05	0.00157	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP1B1—glaucoma	2.92e-05	0.00157	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP2—glaucoma	2.85e-05	0.00154	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTT1—glaucoma	2.71e-05	0.00146	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NARFL—glaucoma	2.69e-05	0.00145	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CA5A—glaucoma	2.69e-05	0.00145	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.45e-05	0.00132	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.42e-05	0.0013	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTM1—glaucoma	2.41e-05	0.0013	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—CDKN2B—glaucoma	2.34e-05	0.00126	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTM1—glaucoma	2.33e-05	0.00126	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.18e-05	0.00118	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCA1—glaucoma	2.16e-05	0.00116	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP1B1—glaucoma	2.16e-05	0.00116	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP9—glaucoma	2.14e-05	0.00116	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—MTHFR—glaucoma	2.13e-05	0.00115	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—MTHFR—glaucoma	2.06e-05	0.00111	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NR3C1—glaucoma	2.05e-05	0.00111	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CA1—glaucoma	2e-05	0.00108	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—APOE—glaucoma	1.98e-05	0.00107	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CAV1—glaucoma	1.96e-05	0.00106	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CTSA—glaucoma	1.93e-05	0.00104	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—glaucoma	1.93e-05	0.00104	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APOE—glaucoma	1.92e-05	0.00104	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CAV1—glaucoma	1.9e-05	0.00103	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CA2—glaucoma	1.83e-05	0.000984	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.78e-05	0.000962	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.78e-05	0.000962	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTM1—glaucoma	1.72e-05	0.00093	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—glaucoma	1.65e-05	0.00089	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MTHFR—glaucoma	1.52e-05	0.000822	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NOS3—glaucoma	1.48e-05	0.0008	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NOS3—glaucoma	1.44e-05	0.000776	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOE—glaucoma	1.42e-05	0.000765	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CAV1—glaucoma	1.41e-05	0.000758	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—glaucoma	1.36e-05	0.000732	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CA1—glaucoma	1.32e-05	0.00071	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—glaucoma	1.32e-05	0.00071	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TXN—glaucoma	1.29e-05	0.000694	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CTSA—glaucoma	1.27e-05	0.000688	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CA2—glaucoma	1.2e-05	0.000649	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.17e-05	0.000633	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.16e-05	0.000627	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NOS3—glaucoma	1.06e-05	0.000573	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTT1—glaucoma	9.97e-06	0.000538	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—glaucoma	9.72e-06	0.000524	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TXN—glaucoma	8.48e-06	0.000457	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.04e-06	0.000434	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCA1—glaucoma	7.94e-06	0.000429	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP1B1—glaucoma	7.94e-06	0.000429	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTT1—glaucoma	6.58e-06	0.000355	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTM1—glaucoma	6.35e-06	0.000343	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTHFR—glaucoma	5.61e-06	0.000303	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCA1—glaucoma	5.24e-06	0.000283	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP1B1—glaucoma	5.24e-06	0.000283	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOE—glaucoma	5.23e-06	0.000282	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CAV1—glaucoma	5.18e-06	0.000279	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTM1—glaucoma	4.19e-06	0.000226	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NOS3—glaucoma	3.91e-06	0.000211	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTHFR—glaucoma	3.7e-06	0.0002	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—glaucoma	3.58e-06	0.000193	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOE—glaucoma	3.45e-06	0.000186	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CAV1—glaucoma	3.41e-06	0.000184	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NOS3—glaucoma	2.58e-06	0.000139	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—glaucoma	2.36e-06	0.000127	CbGpPWpGaD
